Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$28.12 n/a | n/a%
06/30/16 - 04:02 PM ET
Company Profile
Price and Volume
Recent Price 28.12
52 Week High 44.38
52 Week Low 27.01
Avg. Daily Vol. (Mil) 0.70
Beta (3 year) 1.33
Share Related Items
Mkt Cap (Mil) 1,126.51
Shares Out (Mil) 40.06
Float (Mil) 32.25
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.40
Current Ratio 5.40
LT Debt/ Equity 0.38
Total Debt / Equity 0.38
Valuation Ratios
Price Earnings 21.10
Price/Sales 2.15
Price/Book 1.71
Price/Cash Flow 11.50
Per Share Data
Earnings 1.33
Sales 13.05
Book Value 16.48
Cash Flow 2.45
Business Summary
Emergent BioSolutions Inc is a specialty biopharmaceutical company operating in two divisions: Biodefense and Biosciences. Its products include BioThrax, BAT, Anthrasil, VIGIV, RSDL, NuThrax, PreviThrax and GC-072.
General Information
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
www.emergentbiosolutions.com
Industry : Drugs
Sector: Health Care
Employees: 1292
CEO: Daniel J. Abdun-Nabi
Short Interest
Current Month (Mil) 3.75
Previous Month (Mil) 3.78
Short Interest Ratio (Days) 8.50
Management Effectiveness
Return on Equity 9.50
Return on Assets 6.00
Return on Investments 6.90
Profitability
Gross Margin 83.00
EBIT Margin 18.40
Profit Margin 12.00

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter